MEDTRONIC, INC. · Coronary Drug-Eluting Stent · First cleared Apr 2017 · 139 device variants grouped
Total Reports
4,467
Reports (30d)
8
Active Signals
2
Open Recalls
0
What the reports describe · Claripulse analysis
In Vivo Stent Deformation During Advancement
onyx frontier, procedure involving, coronary drug, onyx, frontier
11
reports
Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.
Detection
Evidence
Use of drug-eluting, balloon-expandable resolute onyx coronary stent as a novel treatment strategy for vertebral artery ostial stenosis: Case series
Jaims Lim, et al. · Interventional Neuroradiology · 2022
Short dual antiplatelet therapy after PCI with Resolute Onyx drug-eluting stents in high bleeding risk patients: One-year outcomes from a South Asian cohort.
Jariwala P, et al. · 2025
Use of Onyx Frontier™ for intracranial stenting in stroke patients: A multicenter retrospective study.
Chahine A, et al. · 2024
Sex-Based Outcomes in Patients With High Bleeding Risk After PCI With 1-Month DAPT: Results From the Onyx ONE Clear Study.
Mehran R, et al. · 2026
Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial.
Salinas P, et al. · 2025
Citations indexed from PubMed.
Keep exploring
Perclose ProGlide
ABBOTT VASCULAR INC. · 24,504 reports
Perclose ProStyle
ABBOTT VASCULAR INC. · 19,336 reports
PERCLOSE
ABBOTT VASCULAR INC. · 9,890 reports
Angio-Seal
TERUMO MEDICAL CORPORATION · 6,417 reports
SYNERGY
BOSTON SCIENTIFIC CORPORATION · 5,991 reports
Promus PREMIER
BOSTON SCIENTIFIC CORPORATION · 2,717 reports
Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 2 active signals detected right now.
Get Early AccessUnderstanding this data
